Singclean, a global leader in healthcare solutions, today announced its participation in MEDICA 2026, one of the world's largest medical B2B trade fairs. The event will take place from November 16th to 19th, 2026, at the Düsseldorf Exhibition Centre in Germany. Singclean will showcase its latest innovations at Booth No. Hall 16 / F67-5.

Trusted in 80+ Countries and Regions
Singclean's solutions are currently trusted in over 80 countries and regions worldwide. The company holds prestigious international certifications including CE(MDR), MHRA, ANVISA, HSA, and NMPA, underscoring its commitment to the highest standards of quality, safety, and regulatory compliance.
Key Products on Display
At MEDICA 2026, Singclean will highlight four core product lines:
HA Dermal Filler (Singderm) – A safe and effective solution for facial aesthetics and dermal filling.
Drug Test – Rapid and accurate diagnostic tools for clinical and community health screening.
HA For Bone Joint (Singjoint) – Focused on orthopedic joint health, helping to relieve pain and improve patients' quality of life.
Absorbable Hemostat – Widely used in surgical procedures for safe and efficient hemostasis, supporting faster post-operative recovery.
Meet Us at Hall 16 / F67-5
The Singclean international business team will be available on-site at Hall 16 / F67-5 to discuss product partnerships, regional distribution, and customized solutions.
"We are very excited to meet both new and existing partners at MEDICA 2026," said [Name], International Business Director at Singclean. "Germany is at the heart of the European medical market. We hope to use this platform to introduce Singclean's innovations to a wider international audience and work together to advance global healthcare."
Event Details
Event: MEDICA 2026
Dates: November 16th – 19th, 2026
Venue: Düsseldorf Exhibition Centre, Germany
Singclean Booth: Hall 16 / F67-5
About Singclean
Singclean is a high-tech enterprise specializing in the research, development, manufacturing, and sales of healthcare products. Its portfolio covers medical aesthetics, orthopedics, surgical hemostasis, and in-vitro diagnostics. With products exported to more than 80 countries and regions, Singclean is committed to its brand philosophy of "Towards the Future," delivering high-quality medical solutions to patients and healthcare providers worldwide.
-
singclean | 2026-09-29
A Powerful Alliance for Premium Aesthetics | Singclean Medical x HTL Biotechnology (France)On October 20, 2026, a four-member delegation from French HTL Biotechnology visited Singclean Medical for an exchange and factory tour. This significant meeting aimed to deepen the strategic cooperation between the two parties in the application of premium hyaluronic acid (HA) raw materials and global brand promotion, jointly exploring new growth opportunities for premium injectable HA in the global market. -
singclean | 2026-09-29
Singclean Medical: 15 Years of Chongyang Care — 2026 Event Reaches 337 Elderly Residents Across 6 CommunitiesIn 2011, during the Chongyang Festival—a traditional Chinese occasion dedicated to respecting the elderly—Singclean Medical first entered local communities to deliver cooking oil, rice, and other daily necessities to senior residents. That simple act of care has never stopped. For 15 consecutive years, the company has continued this tradition, bringing warmth and support to the elderly every autumn. -
singclean | 2026-09-29
Singclean’s Medical Sodium Hyaluronate Gel for Bone Joint Gained EU MDR CE Certification, Ranking Among First 3 Globally! 协合医疗骨科医用透明质酸钠凝胶成功斩获欧盟MDR CE认证!跻身全球前三!This achievement sets multiple industry records: it is the first MDR CE certificate for hyaluronic acid-based orthopedic products ever issued by DNV worldwide. Singclean Medical has become the first Chinese company to obtain such certification in this category and has successfully ranked among the first 3 companies globally to secure a viscosupplementation MDR CE certificate. This accomplishment underscores Singclean Medical's technological expertise and international competitiveness in the field of orthopedic biomaterials and hyaluronic acid applications. 此次认证创造了多项行业纪录:这是DNV在全球范围内签发的首张透明质酸骨科类MDR CE证书;协合医疗为中国首家获此证书的企业,更成功跻身全球前三。这一成绩,充分彰显了协合医疗在骨科生物医用材料及透明质酸领域的技术积累与国际竞争力。